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ABSTRACT
Primary peripheral bloodmonocytes are responsible for the hematogenous dissemination of human cytomegalovirus (HCMV)
following a primary infection. To facilitate viral spread, we have previously shownHCMV to extend the short 48-h life span of
monocytes. Mechanistically, HCMV upregulated two specific cellular antiapoptotic proteins, myeloid leukemia sequence 1
(Mcl-1) and heat shock protein 27 (HSP27), to block the two proteolytic cleavages necessary for the formation of fully active
caspase 3 and the subsequent initiation of apoptosis. We now show that HCMVmore robustly upregulatedMcl-1 than normal
myeloid growth factors and that Mcl-1 was the only myeloid survival factor to rapidly induce HSP27 prior to the 48-h cell fate
checkpoint. We determined that HCMV glycoproteins gB and gH signal through the cellular epidermal growth factor receptor
(EGFR) andv3 integrin, respectively, during viral entry in order to drive the increase of Mcl-1 and HSP27 in an Akt-depen-
dent manner. Although Akt is known to regulate protein stability and transcription, we found that gB- and gH-initiated signal-
ing preferentially and cooperatively stimulated the synthesis of Mcl-1 and HSP27 throughmTOR-mediated translation. Overall,
these data suggest that the unique signaling network generated during the viral entry process stimulates the upregulation of se-
lect antiapoptotic proteins allowing for the differentiation of short-lived monocytes into long-lived macrophages, a key step in
the viral dissemination strategy.
IMPORTANCE
Human cytomegalovirus (HCMV) infection is endemic within the human population. Although primary infection is generally
asymptomatic in immunocompetent individuals, HCMV is a significant cause of morbidity andmortality in the immunocom-
promised. The multiorgan inflammatory diseases associated with symptomatic HCMV infection are a direct consequence of the
monocyte-mediated systemic spread of the virus. In order for peripheral bloodmonocytes to facilitate viral dissemination,
HCMV subverts the short 48-h life span of monocytes by inducing the expression of cellular antiapoptotic proteins Mcl-1 and
HSP27. Here, we demonstrate that the rapid and simultaneous upregulation of Mcl-1 and HSP27 is a distinctive feature of
HCMV-inducedmonocyte survival. Moreover, we decipher the signaling pathways activated during viral entry needed for the
robust synthesis of Mcl-1 and HSP27. Identifying the virus-specific mechanisms used to upregulate select cellular factors re-
quired for the survival of HCMV-infected monocytes is important to the development of new classes of anti-HCMV drugs.
Human cytomegalovirus (HCMV), a betaherpesvirus, is highlyprevalent throughout theUnited States, with 50 to 80%of the
population being seropositive (1). HCMV infection is generally
asymptomatic in immunocompetent individuals although infec-
tion has been linked to chronic inflammatory diseases, such as
atherosclerosis and acute infection mononucleosis (2, 3). In con-
trast, HCMV infection causes significant morbidity andmortality
in immunocompromised individuals, including AIDS patients,
neonates, and transplant recipients (4–6). In these patients,
HCMV diseases are diverse with respect to the organ site, includ-
ing eyes (retinitis), brain (encephalopathy), central nervous sys-
tem (polyradiculopathy), lungs (pneumonitis), and gastrointesti-
nal tract (gastroenteritis), which can lead to systemic organ failure
(7, 8). The systemic pathogenesis established by HCMV is depen-
dent on the spread of the virus from the initial point of infection to
peripheral organs.
Monocytes are believed to be the primary cell type responsible
for the systemic dissemination of HCMV during both symptom-
atic and asymptomatic infections (9–11). However, monocytes
have a limited life span of 48 h following release from the bone
marrow, after which these cells either undergo apoptosis or differ-
entiate into long-lived macrophages in the presence of a differen-
tiation stimulus (12, 13). The cell fate decision at this 48-h viability
gate has been attributed to the amount of activated caspase 3 pres-
ent in the cell (14–17).Myeloid differentiation factors granulocyte
macrophage colony-stimulating factor (GM-CSF) and macro-
phage colony-stimulating factor (M-CSF) block the activation of
caspase 3 prior to the 48-h viability checkpoint (14, 17). Similarly,
we found that HCMV infection inhibited the activation of caspase
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3 for the first 48 h postinfection (hpi), facilitating an antiapoptotic
state and promoting monocyte-to-macrophage differentiation
(14, 18, 19). The survival of infected short-lived monocytes is
crucial for viral spread since, unlike monocytes, macrophages are
permissive to viral replication (20–23). However, while both
HCMVandmyeloid growth factors block the activation of caspase
3, the mechanisms of inhibition appear to be distinct. Caspase 3
activation is dependent on two proteolytic cleavage steps; we
found that HCMV inhibits both cleavages, whereas GM-CSF and
M-CSF inhibit only the first cleavage (14, 17), suggesting that
HCMV utilizes a virus-specific mechanism to prevent caspase
3-mediated apoptosis of infected monocytes and allows viral
spread.
We identified two cellular caspase 3 regulatory proteins, my-
eloid cell leukemia 1 (Mcl-1) and heat shock protein 27 (HSP27),
that were rapidly induced following HCMV infection of mono-
cytes (14, 17, 18). Mcl-1, similar to other antiapoptotic members
of the Bcl-2 family of proteins, blocks the release of cytochrome c
from mitochondria and is crucial for the survival of myeloid cells
during myelopoiesis (24, 25). Mcl-1 expression is rapidly lost
upon release of monocytes into circulation and thus acts as a bio-
logical clock, ensuring the short life span of these inflammatory
blood sentinels (18, 26). HSP27 blocks apoptosis by directly bind-
ing to procaspase 3 to inhibit the second proteolytic cleavage re-
quired for the formation of fully activated caspase 3 (27). In con-
trast toMcl-1,monocytes express lowbasal levels ofHSP27,which
is induced late following M-CSF treatment once differentiation
into macrophages is complete (27). We found HCMV to have the
unique ability to rapidly and simultaneously increase both Mcl-1
and HSP27 expression to mediate an early survival state of in-
fected monocytes (14, 18), whereby Mcl-1 acts as the first line of
defense and HSP27 functions as a final safeguard against the
caspase 3-mediated apoptosis. However, themechanism bywhich
HCMV concurrently induces both Mcl-1 and HSP27 remains to
be elucidated.
The lack of viral lytic gene expression in HCMV-infected
monocytes suggests that HCMVmay be regulating cellular signal-
ing pathways during viral entry to rapidly induce Mcl-1 and
HSP27 expression. In support of this, infection with UV-inacti-
vated HCMV or treatment with soluble glycoproteins stimulates
prosurvival events, similar to live virus (18, 20, 28, 29). Indeed, we
found that inhibition of phosphatidylinositol 3-kinase (PI3K)
during viral entry blocked the HCMV-mediated antiapoptotic
state and inhibition of caspase 3, demonstrating that the PI3K
signaling pathway is vital for the survival of infected monocytes
(18). Accordingly, we found that PI3K regulated the rapid induc-
tion of Mcl-1 but not other Bcl-2 family members (18, 30). Tran-
scriptome studies also showed increased HSP27 expression to be
regulated in a PI3K-dependent manner (30). However, despite
also rapidly activating PI3K, M-CSF treatment does not increase
expression of Mcl-1 and HSP27 until 5 and 7 days posttreatment,
respectively, suggesting that a unique regulation of the PI3K path-
way by HCMV during viral entry may promote the expression of
select antiapoptotic proteins (27, 31). Akt (the downstream target
of PI3K) substrate specificity is regulated by the phosphorylation
ratio of two phosphorylation sites, indicating that upstream sig-
naling events are key determinants to the functional outcome of
PI3K signaling (32, 33). HCMV directly stimulates monocyte
PI3K/Akt signaling as a result of HCMV glycoprotein gB binding
to the cellular epidermal growth factor receptor (EGFR) (19, 34,
35). We have also shown that unidirectional cross talk to EGFR
from gH engagement of v3 integrin also contributes to PI3K/
Akt signal strength, which is in contrast to bidirectional cross talk
that occurs between EGFR andv3 during viral entry into fibro-
blasts (19, 36). However, the mechanism by which this virus-spe-
cific signalsome generated during viral entry into monocytes in-
duces Mcl-1 and HSP27 expression in order to stimulate the
survival of infected cells is unclear.
In this study, we examine the mechanism used by HCMV to
increase the expression of Mcl-1 and HSP27 to allow short-lived
monocytes to survive to become long-lived persistently infected
macrophages. We found that while normal myeloid growth fac-
tors activate the PI3K/Akt signaling cascade, only HCMV infec-
tion stimulated the rapid and robust upregulation of both Mcl-1
andHSP27 in a PI3K/Akt-dependent fashion.We showed that the
unique signaling network induced during HCMV entry increases
both the transcription and translation of Mcl-1 and HSP27. More
specifically, activation of both the EGFR andv3 signaling path-
ways contributed to the increased translation ofMcl-1 andHSP27
followingHCMV infection. Taken together, our data indicate that
gB-to-EGFR and gH-to-integrin signaling pathways work coop-
eratively to drive the selective synthesis of Mcl-1 and HSP27 in
order to bypass the 48-h viability gate and promote viral dissem-
ination with the infected host.
MATERIALS AND METHODS
Viral preparation and infection. HCMV (Towne/E strain; passages 39
and 40) was cultured in human embryonic lung (HEL) fibroblasts. Virus
was purified on a 0.5 M sucrose cushion, resuspended in RPMI 1640
medium (Cellgro, Mediatech, Herndon, VA), and used to infect mono-
cytes at a multiplicity of infection (MOI) of 5 for each experiment. We
have previously shown that infection with anMOI of 5 results in 100% of
monocytes being infected with HCMV at 4 h postinfection (hpi) (20).
Monocytes were mock infected using equivalent volumes of RPMI 1640
medium alone. For glycoprotein blocking studies, purified virus was pre-
treated with an anti-gB antibody (US Biological, Salem, MA) or an
anti-gH blocking antibody (Thermo Scientific Pierce, Rockford, IL) for 1
h prior to challenge of monocytes.
Human peripheral blood monocyte isolation. Isolation of human
peripheral blood monocytes was performed as previously described (20).
Briefly, blood was drawn by venipuncture and centrifuged through a Fi-
coll Histopaque 1077 gradient (Sigma-Aldrich, St. Louis, MO) at 200 g
for 30 min at room temperature (RT). Mononuclear cells were collected
and washed six times with phosphate-buffered saline (PBS) to remove
platelets at 200 g for 10min at RT.Monocytes were then layered on top
of a 45% and 52.5% isosmotic Percoll gradient and centrifuged for 30min
at 400  g at RT yielding a 90% monocyte population. Cells were
washed three times with saline at 200  g for 10 min at RT to remove
residual Percoll and suspended in RPMI 1640 medium (Cellgro, Manas-
sas, VA) supplemented with 1% human serum (Sigma-Aldrich, St. Louis,
MO), unless otherwise stated. University Institutional Review Board and
Health Insurance Portability andAccountability Act guidelines for the use
of human subjects were followed for all experimental protocols in our
study.
Western blot analysis. Monocytes were harvested in radioimmuno-
precipitation assay (RIPA) buffer (1MTris-HCl [pH 7.5], 0.5M EDTA, 5
M NaCl, 1% Triton X-100, 10% SDS, and 10% glycerol) containing 1
protease inhibitor mixture (Sigma-Aldrich, St. Louis, MO), 1 phospha-
tase inhibitor mixture II (Sigma-Aldrich, St. Louis, MO), and 1 phos-
phatase inhibitor mixture III (Sigma-Aldrich, St. Louis, MO) for 15 min
on ice. The lysates were cleared by centrifugation at 4°C (5 min at
16,000  g) and stored at 20°C until analyzed. Sample protein was
solubilized in 6 sample buffer (Sigma-Aldrich, St. Louis,MO)by boiling
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for 10min. Equal amounts of total cellular protein from each sample were
separated using SDS-PAGE, followed by immunoblotting. Blots were
blocked in a 5% bovine serum albumin (BSA)–Tris-buffered saline
(TBS)–Tween 20 solution, followed by incubation overnight at 4°C with
an anti-HSP27 antibody, an anti-Mcl-1 antibody, an anti-phospho-gly-
cogen synthase kinase 3 (p-GSK3) antibody, or an anti--actin anti-
body (Santa Cruz Biotechnology, Santa Cruz, CA). Blots were then incu-
bated with diluted horseradish peroxidase (HRP)-conjugated secondary
antibodies for 10 min at RT and developed using ECL Plus (Amersham
Biosciences, Piscataway, NJ) according to the manufacturer’s protocol.
Real-time PCR analysis. Monocyte (2  107 cells) total RNA was
harvested using an E.Z.N.A. Total RNA kit I (Omega, Norcross, GA).
Quantitative reverse transcription-PCR (qRT-PCR) analysis was per-
formed with the following PCR mix: total RNA (100 ng), 2 one-step
SYBR green reactionmix (iTaqDNApolymerase, buffers, and 6-carboxy-
X-rhodamine [ROX] normalization dyes) (Bio-Rad, Hercules, CA),
iScript reverse transcriptase (Bio-Rad, Hercules, CA), and primers (Inte-
gratedDNATechnologies, Coralville, IA). The following forward and reverse
primers were used: Mcl-1, 5=-CTGATTGTTCTGCTCCCTCTAC-3= (for-
ward) and 5=-GTCACAGCACCCATGGTATTA-3= (reverse);HSP27, 5=-TG
CTTCACGCGGAAATACA-3= (forward) and 5=-TTTACTTGGCGGCAGT
CTC-3= (reverse); 18S, 5=-GTAACCCGTTGAACCCCATT-3= (forward)and
5=-CCATCCAATCGGTAGTAGCG-3= (reverse). Relative quantitation was
done to analyze changes in the presence of Mcl-1 or HSP27 relative to 18S
using the algorithm 2CT (where CT is threshold cycle). Statistical signifi-
cance between experimentalmeans (P value) was determined using one-way
analysis of variance (ANOVA). Results are representative of three indepen-
dent experiments fromdifferent donors, unless otherwise stated in the figure
legends.
Cytochrome c release assay. Procedural details were previously de-
scribed (37). Briefly, monocytes were mock or HCMV infected or GM-
CSF or M-CSF treated for 24 h. Cells were then lysed in mitochondrion
isolation buffer (250 mM sucrose, 10 mM Tris-HCl [pH 7.4], 0.1 mM
EGTA) and passed once through a 27-gauge needle or a Dounce homog-
enizer. After samples were centrifuged at 600 g for 10min, the resulting
supernatant was centrifuged at 10,000 g for 10min to obtainmitochon-
dria. Mitochondria were then resuspended in experimental buffer (125
mMKCl, 10mMTris-morpholinepropanesulfonic acid [MOPS], pH 7.4,
5 mM glutamate, 2.5 mM malate, 1 mM KPO4, and 10 M EGTA-Tris,
pH 7.4) to a concentration of 0.3 to 0.5mg/ml protein and exposed to 100
Mconcentrations of synthetic peptides constituting the BH3domains of
BH3-only proteinsNoxaA,Noxa B, Bmf, andBid (GenScript, Piscataway,
NJ) for 40 min at RT. After treatment with BH3 peptides, mitochondria
were separated, and the cytochrome c concentration was measured in the
mitochondrial and supernatant fractions by enzyme-linked immunosor-
bent assay (ELISA) (eBioscience, San Diego, CA).
Analysis of polysome-associated RNAs. Monocytes (10 107 cells)
were treated with 0.1 mg/ml cycloheximide (CHX) (inhibitor of transla-
tion) at 37°C for 10 min prior to harvest. The cells were then washed with
PBS containing CHX at 4°C and pelleted by centrifugation at 4°C. Pellets
were resuspended in polysome lysis buffer (20mMTris-HCl [pH7.4], 140
mM KCl, 5 mM MgCl2, Triton X-100, 10 mM dithiothreitol [DTT], and
0.1 mg/ml CHX) and passed through a 27-gauge needle five times. Resid-
ual insoluble debris andmitochondria were pelleted by centrifugation for
10 min at 15,000  g in a microcentrifuge. The clarified lysate was then
layered onto a linear 10 to 50% sucrose gradient and spun at 32,000 rpm
for 2 h without braking in a Sorvall SW-41 rotor. The locations of ribo-
somal subunits, monosomes, and polysomes in the gradient were deter-
mined by continuous monitoring of the absorbance at an optical density
of 254 nm (OD254) during gradient fractionation using a Brandel gradient
fractionator system coupled to a spectrophotometer (ISCO). We rou-
tinely monitored the efficiency of fractionation by performing Western
blotting for the nuclear protein lamin A/C and the cytoplasmic protein
tubulin (38). Total RNA was extracted from an equal volume of each
gradient fraction using TRIzol, and contaminating DNA was removed
with DNase (Ambion, Austin, TX). The RNA was converted to single-
stranded cDNA using a first-strand cDNA synthesis kit (Life Technolo-
gies, Grand Island, NY), and equal volumes of cDNA were analyzed by
qRT-PCR using the primers and probe sets described above. The copy
number ofMcl-1 or HSP27 transcript in each gradient fraction was deter-
mined by comparing the threshold values for each sample to a standard
curve generated with an Mcl-1 or HSP27 expression vector. The transla-
tion efficiency of each gene was determined by comparing the amount of
mRNA present in polysome-containing fractions to the sum total of the
mRNA present in all fractions of the gradient combined.
RESULTS
HCMV specifically upregulates Mcl-1 and HSP27 in order to
promote an early antiapoptotic state within infected mono-
cytes. Similar to normal myeloid growth factors GM-CSF and
M-CSF, HCMV prevents the intrinsic programming of mono-
cytes to undergo apoptosis by inhibiting the activation of caspase
3 during the first 48 h of infection (14, 17). However, unlike GM-
CSF and M-CSF that simply block the first of two proteolytic
cleavage steps required for the full activation of caspase 3, HCMV
infection induces Mcl-1 and HSP27 to block both cleavages, sug-
gesting a critical role of these two proteins in the early HCMV-
induced prosurvival state (14, 17). Indeed,M-CSF treatment does
not increase expression of Mcl-1 or HSP27 until 5 to 7 days post-
treatment (27, 31), indicating that the simultaneous and rapid
induction of both antiapoptotic regulators may be unique to
HCMV infection. In accordance with Mcl-1 and HSP27 acting as
late survival proteins during M-CSF-induced differentiation, we
found Mcl-1 and HSP27 expression to be increased by 24 hpi in
HCMV-infected but not M-CSF-treated monocytes (Fig. 1A and
B). In GM-CSF-treatedmonocytes, HSP27 was not induced while
Mcl-1 was increased to a lesser extent than with HCMV infection
(Fig. 1A and B), further supporting a vital role for Mcl-1 and
HSP27 in mediating survival following infection of monocytes.
Mcl-1 prevents the release of cytochrome c via inhibition of
Bax and Bak, which are responsible for the formation of pores
within the outer mitochondrial membrane (24). To confirm the
biological activity of Mcl-1, mitochondria were isolated from
HCMV-infected, GM-CSF-treated, or M-CSF-treated cells and
incubated with Noxa A or Noxa B peptide (binds and inhibits
Mcl-1), Bid peptide (directly activates Bax and Bak), or Bmf pep-
tide (binds and inhibits all antiapoptotic Bcl-2 family members)
(39). As expected, Bid and Bmf treatment induced cytochrome c
release regardless of the survival treatment (Fig. 1C). In accord
with our Mcl-1 expression profile, mitochondria from HCMV-
infected and GM-CSF-treated, but not M-CSF-treated, cells re-
leased cytochrome c upon exposure to Noxa A and Noxa B
peptides, indicating that Mcl-1 is responsible for regulating mito-
chondrial membrane potential. These data demonstrate that
HCMV rapidly selects for Mcl-1 as the central Bcl-2 regulator of
cytochrome c release following infection. Together with our pre-
vious functional studies demonstrating that, unlike GM-CSF and
M-CSF, HCMV blocks the second proteolytic cleavage step of
caspase 3 in an HSP27-dependent manner (14), these results sug-
gest that a virus-specific mechanism is responsible for selective
and rapid upregulation of bothMcl-1 andHSP27 in order to drive
the survival of infected monocytes past the 48-h viability gate.
HCMV entry induces a unique signaling network required
for the upregulation of Mcl-1 and HSP27. Our previous studies
demonstrating the absence of viral lytic transcripts during the
early stages of HCMV infection (18), the ability of soluble glyco-
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proteins and UV-inactivated virus particles to stimulate a prosur-
vival state (18, 20, 28, 29), and the PI3K/Akt-dependent inhibition
of caspase 3 (18) indicate that the activation of the PI3K/Akt path-
way during viral entry is crucial for the early survival of infected
monocytes. In support of these observations, inhibition of PI3Kor
Akt with selective small-molecule inhibitors blocked the induc-
tion of Mcl-1 and HSP27 following HCMV infection (Fig. 2A and
B). HCMV gB and gH bind to EGFR and v3, respectively, to
initiate PI3K/Akt signaling (19, 34–36, 40), suggesting that gB-
and gH-initiated signaling may cooperatively regulate Mcl-1 and
HSP27 expression following HCMV infection of monocytes. In-
deed, HCMVparticles coated with neutralizing gB or gH antibod-
ies was unable to induce Mcl-1 and HSP27 (Fig. 2C). It should be
noted that these glycoprotein-neutralizing antibodies have been
validated to bind and block signaling from their respective target
glycoproteins without affecting either the receptor/ligand interac-
tions of the other glycoproteins or the ability of HCMV to bind to
the cell surface (36, 40). Accordingly, inhibition either of EGFR
signaling using an anti-EGFR antibody or AG1478 (AG; an EGFR
kinase-specific inhibitor) or of integrin signaling using an anti-
v3 antibody or PP2 (an inhibitor of Src; a kinase downstreamof
integrins) abrogated HCMV-induced Mcl-1 and HSP27 expres-
sion (Fig. 2C). These data indicate that gB/EGFR and gH/v3
work in concert to orchestrate the rapid upregulation of Mcl-1
and HSP27 and thus the early antiapoptotic state of HCMV-in-
fected monocytes.
HCMV gB- and gH-initiated signaling promotes the tran-
scription of Mcl-1 and HSP27.How the HCMV-induced signal-
some regulates the levels of Mcl-1 and HSP27 is unclear as PI3K/
Akt signaling can control protein expression through protein
stability, transcription, and/or translation. Mcl-1 is a unique
member of the Bcl-2 family with an extremely short half-life of 45
min to 4 h (41, 42). Mcl-1’s stability is regulated byMcl-1 ubiqui-
tin ligase E3 (Mule), which is solely dedicated to binding and
targeting Mcl-1 for polyubiquitination and proteasome-depen-
dent degradation (42, 43). Binding of Mule to Mcl-1 is facilitated
by glycogen synthesis kinase 3 (GSK3) phosphorylation of
Mcl-1. GSK3 activity is blocked by Akt-dependent phosphoryla-
tion on serine 9 (44, 45). Yet, despite the rapid increase in Akt
activity following HCMV infection, GSK3 was not additionally
phosphorylated at 15min postinfection (p.i.) (Fig. 3A), suggesting
that HCMV-activated Akt does not regulate Mcl-1 protein stabil-
ity. Indeed, HCMV-infected monocytes treated with CHX at 24
FIG 1 HCMV infection exhibits enhanced ability to upregulate Mcl-1 and
HSP27. Peripheral blood monocytes were mock infected, HCMV infected,
GM-CSF treated, or M-CSF treated for 24 h. (A and B) Mcl-1 and HSP27
expression was detected by immunoblotting. Membranes were then reprobed
for -actin as a loading control. Data are representative of 3 to 6 independent
blood donors. (C) Mitochondria were isolated and resuspended in 100 M
synthetic peptides constituting the BH3 domains of Noxa A, Noxa B, Bmf, and
Bid. After treatment with BH3 peptides, mitochondria were separated, and the
cytochrome c concentration was measured in the mitochondrial and superna-
tant fractions by ELISA. Data represent the means and standard deviations
from 3 to 5 independent blood donors. *, P	 0.001.
FIG 2 HCMV upregulation of Mcl-1 and HSP27 is triggered by gB- and gH-initiated signaling. For all experiments, monocytes were pretreated with LY294002
(LY; a PI3K inhibitor), MK2206 (MK; an AKT inhibitor), anti-EGFR antibody, AG1478 (AG; an EGFR inhibitor), anti-v3 antibody, or PP2 (an Src inhibitor)
for 1 h. For the experiment shown in panel C, HCMV was pretreated with an anti-gB or an anti-gH antibody for 1 h. For all experiments, cells were then mock
infected or HCMV infected for 24 h. Mcl-1 and HSP27 expression levels were determined by immunoblotting. Membranes were then reprobed for -actin as a
loading control. Data are representative of 3 to 6 independent blood donors.
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hpi resulted in a rapid loss ofMcl-1 protein to levels comparable to
those in mock-infected cells after 1 h of CHX treatment (Fig. 3B).
In contrast, HCMV-induced expression of HSP27, which is a rel-
atively stable protein (46), was unaffected by CHX treatment.
Taken together, these data support an alternative PI3K/Akt-de-
pendent mechanism to stimulate Mcl-1 and HSP27 expression
following HCMV infection.
HCMV rapidly regulates the transcriptional machinery to in-
crease the monocyte antiapoptotic transcriptome leading to the
differentiation and survival of infectedmonocytes (28, 30, 47, 48).
In line with HCMV regulating survival via transcriptional regula-
tion, we found Mcl-1 and HSP27 mRNAs to be elevated at 24 hpi
(Fig. 4A). Moreover, the levels of Mcl-1 and HSP27 transcripts
were unaffected by the presence of the transcriptional inhibitor
actinomycin D (ActD), indicating that HCMV infection directly
increases transcription rather than mRNA stability (Fig. 4A). In
agreement with protein expression, increased transcription of
Mcl-1 and HSP27 was dependent on PI3K/Akt signaling, as dem-
onstrated by the loss of mRNA expression in the presence of PI3K
and Akt inhibitors (Fig. 4B and C). Signaling initiated by both gB
and gHwas required formaximumexpression as neutralization of
either glycoprotein blocked the ability of HCMV to stimulate
transcription of Mcl-1 and HSP27 (Fig. 4D). Accordingly, tran-
scription was also dependent on EGFR and Src activities (Fig. 4E).
FIG 3 HCMV infection does not increase Mcl-1 and HSP27 protein stability. (A) Peripheral blood monocytes were mock or HCMV infected for 15 min.
Phosphorylation of GSK3 at serine 9 and total GSK3 were determined by immunoblotting. Relative levels of p-GSK3 and total GSK3 were determined by
densitometry. (B) Primary monocytes were mock or HCMV infected for 24 h (T0) and further treated for 1 h, 2 h, 3 h, or 4 h with CHX.Whole-cell lysates were
extracted, andMcl-1 andHSP27 protein expressionwas examined by immunoblotting.Membranes were then reprobed for-actin as a loading control. Data are
representative of three independent blood donors.
FIG 4 HCMV-initiated signaling increases Mcl-1 and HSP27 transcription. Primary monocytes were mock or HCMV infected for 24 h and further treated for
1 h with ActD (A). Monocytes were pretreated with LY294002 (LY), MK2206 (MK), AG1478 (AG), or PP2 for 1 h (B, C, and E). Cells were then HCMV infected
for 24 h. For the experiment shown in panel D, HCMV was pretreated with anti-gB or anti-gH antibodies for 1 h. Cells were then HCMV infected for 24 h. For
the experiment shown in panel F, monocytes were mock infected, HCMV infected, GM-CSF treated, or M-CSF treated for 24 h. For all experiments, total RNA
was harvested, and qRT-PCR was performed using primer sets to Mcl-1, HSP27, and 18S rRNA. Data are representative of three to four independent blood
donors. *,P	 0.05; **, P	0.01; ***,P	 0.001.
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However, EGFR appears to play a slightly larger role in mediating
HCMV-induced transcription as the loss of EGFR activity had a
more inhibitory effect on transcription than the loss of Src activity
(Fig. 4E). In contrast to the protein expression studies where
HCMV induced a more robust upregulation of Mcl-1 and HSP27
than myeloid growth factors, Mcl-1 and HSP27 mRNAs were in-
creased similarly by HCMV, GM-CSF, and M-CSF (Fig. 4F), in-
dicating that increased transcription is not the only mechanism
regulating protein expression. Nonetheless, since we have previ-
ously shown gH-initiated signaling to cross talk with EGFR (19),
these data suggest that EGFR activation through both direct gB
binding and indirect gH cross talk, as well as integrin activation
through gH, is required for the increase in Mcl-1 and HSP27
mRNA levels.
HCMV increases translation of Mcl-1 and HSP27 in an
EGFR- and Src-dependent manner. A direct downstream sub-
strate of the PI3K/Akt pathway is the mammalian target of rapa-
mycin (mTOR) kinase, a known regulator of translation and cell
survival (49–51). We found the rapid activation of mTOR, via
phosphorylation at serine 2448, was observed only following
HCMV infection (Fig. 5A), suggesting that the differential regula-
tion of Mcl-1 and HSP27 protein expression between HCMV and
myeloid growth factors may be due to differences in the rates of
mTOR-mediated translation. Inhibition of mTOR with rapamy-
cin significantly limited the ability of HCMV to increase Mcl-1
and HSP27 protein expression (Fig. 5B). To directly examine the
role of translation in controllingMcl-1 andHSP27 expression, we
measured the effect of HCMV infection on the association of the
Mcl-1 and HSP27 mRNAs with ribosomes. Cytoplasmic lysates
were fractionated on linear sucrose gradients to resolve ribosomal
subunits (40S and 60S), monosomes (80S), and polysome-con-
taining fractions (Fig. 5C). The abundance of each mRNA in the
fractions containing polysomes was determined by qRT-PCR.We
found 50% of HSP27 mRNAs in polysome-containing fractions
from HCMV-infected monocytes. In contrast, only 5% of the
HSP27 mRNA was associated with polysomes in uninfected cells
(Fig. 5D). Similarly, 80%ofMcl-1 transcripts were associatedwith
polysomes in HCMV-infected monocytes while only 20% were
associated with polysomes in uninfected cells (Fig. 5D). In con-
trast, GM-CSF and M-CSF treatment did not increase the associ-
ation of either Mcl-1 or HSP27 mRNAs with polysomes, indicat-
ing that the rapid loading of ribosomes onto these transcripts is
unique to the HCMV-induced survival process (Fig. 5D).
Next, we examined the involvement of the HCMV-induced
signaling network in regulating translation. Treatment with AG
completely blocked the phosphorylation of mTOR, suggesting
that EGFR activation contributes to increased translation follow-
ing HCMV infection (Fig. 6A). However, integrin signaling also
contributes to mTOR activation by HCMV in monocytes as PP2
treatment led to a partial reduction of mTOR phosphorylation.
The abundance of polysomes was reduced in the presence of the
EGFR and Src inhibitors as determined by integrating the area
under the curve of the polysome-containing fractions (Fig. 6B and
C). Although these results suggest a role of EGFR and Src signaling
in regulating Mcl-1 and HSP27 translation, we were unable to
directly assess the levels of thesemRNAs actively translating in the
absence of these signaling pathways as AG or PP2 treatment pre-
ventsMcl-1 orHSP27 transcription (Fig. 4E) and likely their load-
ing into ribosomes, resulting in insufficient levels to detect upon
fractionation (18, 40). Nonetheless, these data suggest that the
disparity between the capacities of HCMV and myeloid growth
factors to induce Mcl-1 and HSP27 is due to the unique ability of
the HCMV-induced signalsome to rapidly stimulate mTOR-me-
diated translation.
DISCUSSION
Differentiation of infectedmonocytes is critical toHCMVdissem-
ination and the establishment of chronic infection in peripheral
FIG 5 HCMV stimulates mTOR activity to promote Mcl-1 and HSP27 translation. For the experiments shown in panels A, C, and D, monocytes were mock
infected, HCMV infected, GM-CSF treated, orM-CSF treated for 24 h. For the experiment shown in panel B, monocytes were pretreated for 1 h with rapamycin
and then mock or HCMV infected for 24 h. (A and B) Phosphorylation of mTOR at serine 2448 was determined via immunoblotting, and membranes were
reprobed for -actin as a loading control. (C) Cytoplasmic lysates from treated cells were fractionated over linear 10 to 50% sucrose gradients with continuous
monitoring of theUVabsorbance at theOD254. (D) qRT-PCRwas performed to determine the levels ofMcl-1 andHSP27mRNAswithin the individual fractions.
The percentage of translating mRNA was determined by dividing the amount of polysome-associated mRNA by the sum total of the mRNA in all gradient
fractions combined. Data in all panels are representative of three independent blood donors.
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organ sites since, in contrast to monocytes, macrophages are per-
missive for viral replication (20–23). Monocytes have a biologi-
cally programmed short life span of 48 h in the absence of a sur-
vival stimulus (12, 13). We have previously shown that HCMV
infection promptly inhibits caspase 3 activation to allow infected
monocytes to successfully navigate the 48-h viability gate (14, 18).
In the absence of viral antiapoptotic proteins during the critical
first 48-h time period of infection (18), we determined that
HCMV rapidly upregulated Mcl-1 and HSP27 to block the two
proteolytic cleavage steps necessary for the full activation of
caspase 3 (14). In contrast, normal myeloid growth factors simply
block the first cleavage of caspase 3 to promote monocyte-to-
macrophage survival (14, 17), indicating that the rapid induction
of Mcl-1 and HSP27 may be unique to HCMV infection. In the
current study, we provide evidence that anHCMV-specific signal-
some generated during viral entry is responsible for the selective
increase in Mcl-1 and HSP27 following infection of monocytes.
Studies have demonstrated that increased Mcl-1 and HSP27
activity plays a vital role during the later stages of the myeloid
maturation process induced by myeloid growth factors. Accord-
ingly, a more rapid and robust increase in Mcl-1 and HSP27 was
observed following HCMV infection than with GM-CSF and M-
CSF treatments. The reason for this difference in the kinetics of
Mcl-1 and HSP27 upregulation by HCMV and myeloid growth
factors is unclear. However, we speculate that although both
HCMV and growth factors must subvert the intrinsic biological
programming of monocytes to activate caspase 3, HCMV must
also abrogate the antiviral proapoptotic signaling initiated by host
cells in response to infection (52). In support of this, transcrip-
tome studies suggest that HCMV infection causes a surge in the
intracellular proapoptotic proteinmilieu ofmonocytes (47). Con-
sequently, HCMV likely evolved a more stringent strategy to en-
sure that caspase 3 is not cleaved into the fully active form. To-
gether with our previous data showing that HCMV-induced
Mcl-1 and HSP27 work in concert to block caspase 3-mediated
apoptosis (14, 18), our data here demonstrate that the rapid and
robust upregulation of these antiapoptotic proteins is unique to
HCMV infection and required for the survival of infected mono-
cytes.
The specific induction of Mcl-1 and HSP27 indicates an evo-
lutionary advantage of these caspase 3 regulators to mediate the
survival of HCMV-infected monocytes. Mcl-1, unlike other
highly stable Bcl-2 family members (53), has a short half-life that
allows for short-term inducible effects on cell viability and the
rapid control of death signals. Our data hint at the presence of a
basal stable and an HCMV-induced unstable pool of Mcl-1 fol-
lowing infection as treatment with CHX returned Mcl-1 expres-
sion to the same level as that in uninfected cells. Because we have
shown that intermediate levels of caspase 3 activation after the
48-h viability gate are required for myeloid differentiation to oc-
cur (14), the induction of an unstable pool of Mcl-1 by HCMV
likely halts early caspase 3 activation while allowing for a temporal
activation of caspase 3 once infectedmonocytes have bypassed the
48-h checkpoint. The reason for selecting HSP27 activity over
inhibitor of apoptosis proteins (IAPs), which also block the sec-
ond cleavage of caspase 3 (54–56), during this crucial cell fate
decision period is likely a result of the antiviral activity possessed
by the multifunctional IAPs (57). Indeed, HSP27 has not been
shown to possess any antiviral activity, and several viruses exploit
the nonapoptotic functions of HSP27 to enhance viral replication
(58–60). Thus, the unique properties of Mcl-1 and HSP27 appear
to be ideal for balancing the acquisition of an antiapoptotic state
with the progression of the myeloid differentiation process of
HCMV-infected monocytes.
The establishment of an antiapoptotic state within infected
monocytes requires the activation of the PI3K/Akt signaling path-
way during viral entry (18, 19, 48). HCMV gB and gH binding to
EGFR andv3, respectively, cosignals the activation of PI3K/Akt
signaling following infection of monocytes (19, 34–36, 40). Ac-
cordingly, we found that signaling initiated by both gB and gHwas
required for maximum Mcl-1 and HSP27 expression. However,
GM-CSF andM-CSF, which also rapidly activate PI3K/Akt signal-
ing, were unable to induce robust Mcl-1 and HSP27 expression,
suggesting that theHCMV-induced signalsomemay be regulating
Akt in a distinctmanner to allow the production of select antiapo-
ptotic proteins. Akt substrate specificity is regulated by the phos-
phorylation ratio between two residues at serine 473 (S473) and
threonine 308 (T308) (32, 33). Because the p-S473/p-T308 ratio
followingHCMV infection is different from that found after treat-
ment with myeloid growth factors (data not shown), we suggest
that HCMV-activated Akt possesses unique substrate specificity
FIG 6 HCMV-induced translation of Mcl-1 and HSP27 is predominantly
EGFR dependent. (A and B) Monocytes were pretreated with AG or PP2 for 1
h. Cells were then mock or HCMV infected for 24 h in the presence of either
inhibitor. Levels of p-mTOR and -actin were determined by densitometry
(A). Sample treatments were normalized to the levels in HCMV-infected
monocytes. Cytoplasmic lysates from treated cells were fractionated over lin-
ear 10 to 50% sucrose gradients with continuous monitoring of the UV absor-
bance at the OD254 (B). (C) To determine the total abundance of polysomes,
the area below the polysome-containing fractions was measured using ImageJ
software. The background level of translation was removed by subtracting the
polysomal fraction area of mock-infected cells from the different treatment
groups. Data are representative of three independent blood donors.
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and thus downstream effects. In support of this is the observation
that GSK3was not phosphorylated while mTOR was phosphor-
ylated following HCMV infection. How HCMV alters Akt phos-
phorylation patterns and thus substrate specificity is under
investigation. Nonetheless, our data suggest that the targeted up-
regulation of a specific subset of Akt-dependent proteins by
HCMVmediates the survival of infected monocytes.
The differential ability of the HCMV-induced signalsome to
upregulate Mcl-1 and HSP27 appears to occur at the level of
translation as only HCMV promoted the rapid loading of ribo-
somes onto Mcl-1 and HSP27 mRNAs while both HCMV and
myeloid growth factors stimulated transcription of Mcl-1 and
HSP27. Our data further suggest that EGFR and v3 cosig-
naling contributes to enhanced translation following HCMV
infection although EGFR appears to be the master regulator as
inhibition of EGFR completely abrogated HCMV-induced
mTOR phosphorylation and translation. Even though PI3K/
Akt/mTOR is a principle pathway regulating translation (61–
63), we found that only HCMV, and not growth factors, rapidly
activated mTOR, suggesting that the HCMV-specific signaling
network distinctly regulates Akt activity in order to rapidly
target mTOR phosphorylation. How the HCMV-induced sig-
nalsome alters Akt activity to possess unique substrate speci-
ficity is unclear. The concurrent targeting of Akt by EGFR ki-
nase (EGFRK) and Src may induce a unique Akt activation
profile as both have been shown to directly regulate Akt/
mTOR-dependent translation (64, 65). Alternatively, gH/Src
signaling may also directly control mTOR-mediated transla-
tion as Src has also been shown to regulate mTOR in an Akt-
independent manner (66). However, our data suggest that
cross talk from the gH/v3/Src pathway may modify EGFR
activity, resulting in an atypical activation of Akt. In support of
this is the observation that blocking EGFR activity completely
abrogated HCMV-induced transcription and translation,
whereas a partial reduction was observed upon Src inhibition.
Moreover, we have previously found that unidirectional cross
talk from gH/v3/Src signaling to EGFR occurs following
HCMV infection of monocytes and that HCMV induces a
chronic versus a transient EGF-mediated activation of EGFR in
monocytes (19); LaMarca et al. found that HCMV stimulates a
distinct phosphorylation profile on the cytoplasmic tail of
EGFR compared to that of EGF (the cognate ligand of EGFR)
(67). Regardless, our study demonstrates that the simultaneous
activation of EGFR and v3 during HCMV entry into mono-
cytes leads to a rapid and robust activation of mTOR, allowing
for the early translation of Mcl-1 and HSP27.
HCMV entry induces a signaling network necessary for the
survival of infected monocytes, a necessary step in the hematoge-
nous dissemination process. Our work here begins to decipher the
molecular mechanisms by which HCMV selectively increases the
expression of Mcl-1 and HSP27, which cooperatively function to
block the activation of caspase 3 within HCMV-infected mono-
cytes. We found that gB/EGFR and gH/integrin cooperatively
function to increase Mcl-1 and HSP27 expression (Fig. 7). Fur-
thermore, EGFR activation from cross talk from the gH/v3/Src
cascade may also contribute to the upregulation of Mcl-1 and
HSP27. We also demonstrate that although Akt is known to pro-
mote protein stability, HCMV-activated Akt preferentially regu-
lates the synthesis of antiapoptotic proteins though an increase in
transcription and an increase in mTOR-mediated translation.
Overall, we suggest that HCMV rapidly induces the survival of
newly infectedmonocytes through a unique signalsome generated
during the viral entry process. Specifically, our data indicate that
gB- and gH-initiated signaling stimulates the expression of select
antiapoptotic proteins, Mcl-1 and HSP27, in order to block
caspase 3-mediated apoptosis and allow monocyte-to-macro-
phage differentiation. Deciphering the distinct mechanisms by
which HCMV induces monocyte survival may allow the develop-
ment of novel pharmaceutical drugs that directly target HCMV-
infected monocytes.
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FIG 7 A model for the selective upregulation of Mcl-1 and HSP27 during
HCMV infection of monocytes. HCMV gB binding to EGFR and gH binding
to v3 trigger the PI3K/Akt pathway. In addition, cross talk from the gH/
V3/Src signaling cascade contributes to the activation of EGFR, leading to
Akt activity exhibiting a virus-directed substrate specificity. The induction of
unknown transcription factors stimulates the transcription of Mcl-1 and
HSP27. Concomitantly, HCMV-activated Akt rapidly phosphorylates mTOR
to drive the translation of Mcl-1 and HSP27. The rapid synthesis of Mcl-1 and
HSP27 blocks the two proteolytic cleavages necessary for the formation of fully
activated caspase 3 prior to the 48-h viability gate, thus allowing for the survival
and differentiation of infected monocytes.
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